News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tokai Pharmaceuticals To Present At The Leerink Swann and Company Global Healthcare Conference


2/5/2014 7:57:04 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer and other hormonally driven cancers, today announced that Jodie Morrison, president and chief executive officer, will present an overview of the company and the recently presented interim Phase 2 data on its lead prostate cancer drug candidate galeterone at the Leerink Global Healthcare Conference on Wednesday, February 12, 2014 at 3:05 p.m. (ET) in New York City.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES